Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benchmarking large language models against practicing clinicians on psychopathological assessment.

NPJ digital medicine·2026
Same author

'Psycholag': a new term to describe the delay between physical and psychological improvement in patients with skin disease.

The British journal of dermatology·2024
Same author

British Association of Dermatologists guidelines for the management of adults with delusional infestation 2022.

The British journal of dermatology·2022
Same author

Influence of mental health professionals' attitudes and personality traits on decision-making around coercion: Results from an experimental quantitative survey using case vignettes.

Acta psychiatrica Scandinavica·2022
Same author

A German Version of the Staff Attitude to Coercion Scale. Development and Empirical Validation.

Frontiers in psychiatry·2021
Same author

Understanding the biological basis of dyslexia at a neural systems level.

Brain communications·2020

Related Experiment Video

Updated: May 25, 2026

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model
05:32

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model

Published on: August 11, 2023

Menopause and schizophrenia.

Rina Gupta1, Iyas Assalman, Ronald Bottlender

  • 1North East London Foundation Trust, Goodmayes Hospital, Ilford, Essex, UK. gupta.rina@yahoo.com

Menopause International
|February 7, 2012
PubMed
Summary

Menopause significantly impacts women's mental health, particularly those with schizophrenia. Estrogen's protective role suggests hormone replacement therapy may benefit these patients.

Area of Science:

  • Reproductive endocrinology and psychiatry.
  • Neurobiology of psychosis and aging.

Background:

  • Menopause is a significant life transition with evolving understanding since the 11th century.
  • The impact of menopause on severe mental illnesses like schizophrenia remains under-researched.
  • Estrogen's antidopaminergic properties are recognized, suggesting a link to psychosis risk during menopause.

Purpose of the Study:

  • To review the current understanding of menopause's effect on mental health in women.
  • To explore the potential role of estrogen and hormone replacement therapy in managing schizophrenia during menopause.
  • To emphasize the need for a comprehensive understanding of menopause in schizophrenia patients.

Main Methods:

  • Literature review of existing research on menopause, mental health, and schizophrenia.

More Related Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Related Experiment Videos

Last Updated: May 25, 2026

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model
05:32

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model

Published on: August 11, 2023

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

  • Analysis of studies investigating estrogen's neuroprotective and antidopaminergic effects.
  • Synthesis of findings related to hormone replacement therapy in menopausal women with psychosis.

    • Main Results:

    • Estrogen may offer protection against new psychotic disorders due to its antidopaminergic action.
    • Hormone replacement therapy is hypothesized to be beneficial for menopausal women with schizophrenia.
    • A knowledge gap exists regarding menopause's specific impact on schizophrenia.

    Conclusions:

    • Understanding menopause is crucial for managing schizophrenia in affected women.
    • Further research is needed to validate the benefits of hormone replacement therapy in this population.
    • Integrating gynecological and psychiatric care may improve outcomes for menopausal women with schizophrenia.